- Report
- September 2025
- 327 Pages
Global
From €3770EUR$4,197USD£3,220GBP
- Report
- November 2025
- 270 Pages
Global
From €4446EUR$4,950USD£3,798GBP
- Report
- November 2025
- 307 Pages
Global
From €4042EUR$4,500USD£3,453GBP
- Report
- April 2026
- 120 Pages
Global
From €5344EUR$5,950USD£4,565GBP
- Report
- March 2026
- 120 Pages
Global
From €5344EUR$5,950USD£4,565GBP
- Report
- December 2025
- 150 Pages
Global
From €5344EUR$5,950USD£4,565GBP
- Report
- March 2026
- 135 Pages
Global
From €2694EUR$2,999USD£2,301GBP
€3592EUR$3,999USD£3,068GBP
- Report
- May 2026
- 140 Pages
Global
From €2694EUR$2,999USD£2,301GBP
€3592EUR$3,999USD£3,068GBP
- Report
- August 2026
- 174 Pages
Global
From €5254EUR$5,850USD£4,488GBP
- Report
- August 2026
- 370 Pages
Global
From €5254EUR$5,850USD£4,488GBP
- Report
- August 2026
- 182 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- August 2026
- 194 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- August 2026
- 188 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- August 2026
- 190 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- August 2026
- 192 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- January 2026
- 196 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- January 2026
- 194 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- January 2026
- 186 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- January 2026
- 181 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- January 2026
- 184 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP

The Whole Blood market is a subset of the biopharmaceutical industry, which focuses on the development and production of therapeutic products derived from living organisms. Whole Blood is a type of biopharmaceutical product that is derived from human blood, and is used to treat a variety of medical conditions. Whole Blood is typically collected from healthy donors and processed to remove any potential contaminants. It is then stored and distributed to medical facilities for use in transfusions and other treatments.
Whole Blood is used to treat a variety of medical conditions, including anemia, trauma, and cancer. It is also used to replace lost blood during surgery, and to treat patients with severe blood loss due to trauma or illness. Whole Blood is also used in research and development, as it can provide valuable insights into the human body and its response to various treatments.
Some of the major companies in the Whole Blood market include CSL Behring, Grifols, Octapharma, and Kedrion. These companies are involved in the collection, processing, storage, and distribution of Whole Blood products. Show Less Read more